Guideline registry — degenerative disc disease and low-back pain¶
Last checked: 2026-08-30
Scope¶
A live PubMed E-utilities title search on 2026-08-30 returned ten DDD-linked guideline records, all addressing a procedure, pain phenotype, herniation or fusion selection rather than imaging-defined DDD as one uniform condition. This registry therefore includes low-back-pain, radicular, surgical, occupational and regenerative guidance that governs how the label is used. Status reflects the issuing body’s site on the access date, not a legal determination.
Master table¶
| Body | Year | Region | Scope | Citation / live source | Status |
|---|---|---|---|---|---|
| World Health Organization | 2023 | Global | Nonsurgical chronic primary low-back pain in primary/community care | WHO publication, accessed 2026-08-30 | current |
| NICE | 2016; update 2020 | England/Wales | Low-back pain and sciatica, age ≥16 | NG59 recommendations, accessed 2026-08-30 | current; last updated 2020 |
| VA/DoD | 2022 | United States | Diagnosis and treatment of low-back pain | VA/DoD guideline hub, accessed 2026-08-30 | current; site says update in progress |
| North American Spine Society | 2021 | North America | Diagnosis and treatment of adult low-back pain | NASS guideline, accessed 2026-08-30 | current listed document |
| Australian Commission on Safety and Quality in Health Care | 2022 | Australia | New acute low-back-pain episode: assessment, management, review/referral | Clinical Care Standard, accessed 2026-08-30 | current; page updated 2026 |
| American College of Occupational and Environmental Medicine | 2020 | United States | Working-age low-back disorders; non/minimally invasive care | ACOEM summary guideline, accessed 2026-08-30 | current document; update cycle due/unclear |
| Belgian Health Care Knowledge Centre (KCE) | 2017 | Belgium | Low-back and radicular pain | KCE Report 287A, accessed 2026-08-30 | aging; update project planned 2026 |
| Danish Health Authority | 2016 | Denmark | Recent-onset low-back pain | English quick guide, accessed 2026-08-30 | historical/current status unclear |
| German AWMF/NVL | 2017 | Germany | Nonspecific low-back pain | NVL Kreuzschmerz v2, accessed 2026-08-30 | expired 2021 |
| American College of Physicians | 2017 | United States | Noninvasive acute, subacute and chronic nonradicular low-back pain | Qaseem et al., PMID 28192789; ACP source, accessed 2026-08-30 | ACP lists inactive; partially updates 2007 |
| ACP/American Pain Society | 2007 | United States | Diagnosis/treatment of low-back pain | ACP inactive-guideline registry, accessed 2026-08-30 | superseded in part → ACP 2017; inactive |
| North American Spine Society | 2012 | North America | Lumbar disc herniation with radiculopathy | NASS clinical-guideline registry, accessed 2026-08-30 | older; remains listed |
| American Society of Interventional Pain Physicians | 2019 | United States/international | Responsible use of biologics for low-back pain | Navani et al., PMID 30717500; ASIPP source, accessed 2026-08-30 | superseded/updated → ASIPP 2025 |
| American Society of Interventional Pain Physicians | 2025 | United States/international | Regenerative therapies for chronic low-back pain | Manchikanti et al., PMID 41481869; ASIPP source, accessed 2026-08-30 | current update |
| American Society of Pain and Neuroscience | 2022 | United States/international | Interventional treatments for low-back pain | Sayed et al., PMID 36510616 | published guideline; 2026-08-30 PubMed sweep found no later society-wide replacement |
| AANS/CNS Joint Section | 2014 | United States | Fusion procedures for lumbar degenerative disease: injection selection and economic assessment | Watters et al., PMID 24980590; Kaiser et al., PMID 24980580 | historical update; current supersession status unclear |
| Belgian KCE care pathway | 2017 | Belgium | Multidisciplinary low-back/radicular care pathway | KCE Report 295B, accessed 2026-08-30 | KCE warns guideline may be obsolete after 5 years |
Per-guideline entries¶
WHO 2023¶
- Population: adults, including older adults, with chronic primary low-back pain in primary and community care.
- Excludes: surgery and other interventions normally delivered in secondary/tertiary care; workplace interventions.
- Contribution: global, discipline-neutral package emphasizing person-centered, coordinated combinations rather than single isolated modalities.
- Supported directions: education/self-care, exercise, selected physical and psychological therapies, NSAIDs in appropriate contexts.
- Against routine use: includes braces/belts, traction and opioids for most people in most contexts.
- Evidence companion: coordinated review series (Cancelliere 2023, PMID 37991650; Verville 2023, PMID 37991647; Southerst 2023, PMID 37991651).
- DDD boundary: does not validate an imaging-defined disc pain source.
NICE NG59 (2016; pharmacological sciatica update 2020)¶
- Population: low-back pain with or without sciatica in people aged 16 and older.
- Imaging: do not routinely image in non-specialist care; consider specialist imaging only if likely to change management.
- Noninvasive care: tailored self-management, normal activity and group exercise; manual therapy only in a package with exercise, with or without psychological therapy.
- Against: traction, acupuncture, several electrotherapies, spinal injections for low-back pain, chronic opioids and gabapentinoids for low-back pain.
- Invasive: epidural local anesthetic/steroid may be considered for acute severe sciatica; fusion only in an RCT for low-back pain; do not offer disc replacement for low-back pain.
- Status: official page says published 2016, last updated 11 December 2020.
VA/DoD 2022¶
- Population: adults with low-back pain in VA/DoD systems.
- Structure: initial evaluation and management algorithms plus 39 evidence-based recommendations.
- Contribution: integrated diagnostic, nonpharmacologic, pharmacologic and systems guidance, with patient tools.
- Status: the official hub was last updated in 2025 and the central guideline index in 2026 states the lower-back-pain CPG is being updated.
- Watch: replacement version and changes to pharmacology/intervention recommendations.
NASS 2021 low-back-pain guideline¶
- Scope: a defined subset of adult low-back pain; the guideline explicitly excludes some neurological deficit and below-knee leg-pain presentations.
- Domains: diagnosis, imaging, medical/psychological, physical medicine/rehabilitation, interventional, surgical and cost-utility.
- Contribution: spine-specialty evidence grading across the care continuum.
- Boundary: recommendations should not be generalized to excluded radicular/neurological populations.
Australian Low Back Pain Clinical Care Standard 2022¶
- Population: patients aged ≥16 with a new acute episode, with or without leg pain.
- Eight statements: assessment, psychosocial factors, imaging stewardship, education, activity, medicines, review and referral.
- System feature: includes 11 implementation indicators.
- Boundary: explicitly excludes ongoing chronic-pain management, surgery indications and specific degenerative disorders.
- Contribution: unusually strong implementation, consumer and equity framing.
ACOEM 2020¶
- Population: working-age adults with acute, subacute and chronic low-back disorders.
- Evidence base: abbreviated publication reports 121 recommendations from a larger 862-page guideline; evidence sought across DDD, radiculopathy, spondylolisthesis, facet disease, failed surgery and stenosis.
- Contribution: work-disability, auditability and return-to-function perspective.
- Access caveat: full guideline is tied to MDGuidelines; the official ACOEM PDF is an abbreviated peer-reviewed summary.
Belgian KCE 2017 and pathway¶
- Scope: acute/chronic low-back and radicular pain with multidisciplinary input.
- Direction: demedicalization, continued movement, selective imaging and early risk stratification.
- Status: KCE explicitly warns its 2017 care-pathway guideline may be obsolete after five years.
- Update: KCE’s live project page states an update is planned in 2026 because the underlying literature review is approaching ten years old.
- Supersession chain: KCE 2017 remains the available base → KCE update project 2026 (not yet a replacement).
Danish Health Authority 2016¶
- Scope: treatment of recent-onset low-back pain.
- Contribution: national quick guide with evidence-based conservative-care recommendations.
- Status limitation: live source resolves, but a clear current/superseded declaration was not found in this session; treat as historical pending confirmation.
German NVL Kreuzschmerz v2 (2017)¶
- Scope: coordinated cross-sector care for nonspecific low-back pain.
- Status: official AWMF page states valid through 30 December 2021; it is expired.
- Use: historical comparison only; do not call current.
- Watch: replacement/re-registration in AWMF.
ACP 2017 and ACP/APS 2007¶
- ACP 2017: noninvasive acute/subacute/chronic nonradicular low-back pain; nonpharmacologic chronic care first, then selective medicines (PMID 28192789).
- ACP status: the official ACP registry now places it under inactive guidelines.
- ACP/APS 2007: broader diagnosis/treatment document; ACP says the 2017 guideline is a partial update.
- Chain: ACP/APS 2007 → partially superseded by ACP 2017 → ACP 2017 now inactive, with no replacement identified on the live ACP page.
NASS 2012 disc herniation with radiculopathy¶
- Scope: disc herniation with radiculopathy, not axial DDD.
- Contribution: preserves the critical boundary between root disease and structural degeneration.
- Status: still listed among completed NASS guidelines but is older than ten years; check for update before use.
ASIPP regenerative guidance 2019 → 2025¶
- 2019 contribution: responsible, safe and effective biologic use; evidence and governance framing (PMID 30717500).
- 2025 contribution: updated evidence-based recommendations for regenerative therapies (PMID 41481869).
- Chain: ASIPP 2019 → updated/superseded by ASIPP 2025.
- Conflict boundary: interventional-society grading may be more permissive than general low-back-pain guidelines; product-specific randomized evidence remains limited.
ASPN interventional guideline 2022¶
- Scope: evidence-based assessment of established and emerging interventional treatments across low-back-pain phenotypes (Sayed 2022, PMID 36510616).
- Contribution: places procedure-specific selection, effectiveness and safety in one interventional pathway.
- Boundary: a procedure guideline does not validate imaging-defined DDD as a uniform diagnosis; radicular, facet, sacroiliac, vertebrogenic and discogenic evidence must remain separated.
- Conflict: its eligible procedures and evidentiary thresholds are broader than NICE’s recommendation against spinal injections for nonspecific low-back pain.
- Status limitation: the peer-reviewed document resolved in the live PubMed sweep; an official current/superseded declaration was not established, so no stronger currency claim is made.
AANS/CNS fusion-guideline update 2014¶
- Injection/selection chapter: medial-branch ablation was suggested for 3–6 months of relief in selected nonradicular facet-mediated pain, while diagnostic medial-branch blocks were not supported as predictors of lumbar-fusion outcome (Watters 2014, PMID 24980590).
- Economic chapter: requires preference-based quality-of-life measurement such as EQ-5D to translate cost and outcomes into QALYs; an eight-year analysis informed its historical economic comparison (Ghogawala 2014, PMID 24980580).
- Boundary: neither chapter establishes a reliable painful-disc test or a generic fusion indication for an MRI degeneration label.
- Status: retained as historical guidance because a live supersession chain was not verified in this session.
Agreements¶
| Topic | Broad agreement |
|---|---|
| DDD label | Imaging degeneration alone does not define treatment |
| Assessment | Screen for serious pathology and neurological deficit |
| Imaging | Avoid routine early imaging when uncomplicated |
| Education | Explain, reassure and support self-management |
| Activity | Continue/restore normal activity |
| Exercise | Structured exercise for persistent pain |
| Opioids | Avoid routine long-term use |
| Radiculopathy | Separate from axial pain |
| Surgery | Requires selected phenotype and concordance |
| Biologics | Evidence/product governance is essential |
Disagreements and gaps¶
| Topic | Guideline disagreement | Evidence gap |
|---|---|---|
| Acupuncture | ACP includes as an option; NICE says do not offer | Context, comparator and cost effectiveness |
| Manual therapy | Offered alone or only in a package | Active ingredient and durability |
| Duloxetine | ACP second-line option; NICE says do not offer antidepressants for low-back pain | Small effect and phenotype selection |
| Spinal injections | NICE says do not offer for low-back pain; interventional bodies endorse selected procedures | Discogenic construct and sham evidence |
| Fusion | NICE limits to RCT for low-back pain; spine practice/guidance permits selected surgery | Valid level-selection and active comparator |
| Disc replacement | NICE says do not offer for low-back pain; device/spine evidence supports narrow DDD eligibility | Lifetime device-specific net benefit |
| Basivertebral ablation | Absent from older general guidelines | Independent replication and placement in pathway |
| Regenerative therapy | General guidelines largely omit; ASIPP offers evidence grading | Product standardization and late safety |
| Interventional pathway | ASPN/ASIPP evaluate selected procedures; NICE is substantially more restrictive for nonspecific axial pain | Independent sham replication, phenotype boundaries and opportunity cost |
| Fusion prediction | Historical AANS/CNS guidance rejects medial-branch blocks as fusion predictors; surgical selection still uses heterogeneous tests | Externally validated treatment-effect model |
| Imaging communication | Stewardship endorsed; wording rarely specified | Nocebo-reducing report trials |
| Work participation | Prominent in occupational guidance, less elsewhere | Cross-system implementation |
Watch list¶
| Body/document | Watch item | Next check |
|---|---|---|
| VA/DoD low-back-pain CPG | Official site says update in progress | 2026 Q4 |
| KCE Belgium | Planned 2026 update project | 2027 Q1 |
| ACP | Replacement for inactive 2017 guideline | 2027 Q1 |
| NICE NG59 | New evidence-triggered review | 2027 Q1 |
| NASS low-back pain | Revision/update status | 2027 Q1 |
| NASS disc herniation | Replacement for 2012 document | 2027 Q1 |
| ACOEM | Five-year comprehensive update | 2027 Q1 |
| German AWMF/NVL | Replacement for expired v2 | 2027 Q1 |
| Danish Health Authority | Current/superseded declaration | 2027 Q1 |
| ASIPP regenerative | New product-specific trials and safety updates | 2027 Q1 |
| WHO | Implementation tools and updates | 2027 Q1 |
| ASPN interventional guideline | Official revision or supersession statement | 2027 Q1 |
| AANS/CNS lumbar-fusion series | Current replacement/supersession chain | 2027 Q1 |
Sources checked¶
- World Health Organization — “WHO guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings,” https://www.who.int/publications/i/item/9789240081789, accessed 2026-08-30.
- NICE — “Low back pain and sciatica in over 16s: recommendations,” https://www.nice.org.uk/guidance/NG59/chapter/recommendations, accessed 2026-08-30.
- VA/DoD — “Diagnosis and Treatment of Low Back Pain (2022),” https://www.healthquality.va.gov/guidelines/pain/lbp/index.asp, accessed 2026-08-30.
- NASS — “Clinical Guidelines,” https://www.spine.org/Research/Clinical-Guidelines/Low-Back-Pain, accessed 2026-08-30.
- Australian Commission on Safety and Quality in Health Care — “Low Back Pain Clinical Care Standard,” https://www.safetyandquality.gov.au/clinical-care-standards/low-back-pain, accessed 2026-08-30.
- KCE — “Clinical guideline on low-back and radicular pain,” https://kce.fgov.be/nl/publicaties/alle-rapporten/klinische-richtlijn-rond-lage-rugpijn-en-radiculaire-pijn, accessed 2026-08-30.
- ACOEM — “Non-Invasive and Minimally Invasive Management of Low Back Disorders,” https://acoem.org/acoem/media/News-Library/Practice-Guidelines-Non_Invasive-Low-Back-Pain-March-2020-JOEM_1.pdf, accessed 2026-08-30.
- AWMF — “Nationale VersorgungsLeitlinie Kreuzschmerz,” https://www.awmf.org/aktuelles/awmf-aktuell/nationale-versorgungsleitlinie-kreuzschmerz-2, accessed 2026-08-30.
- Danish Health Authority — “National clinical guideline for recent-onset low back pain,” https://sundhedsstyrelsen.dk/da/udgivelser/2016/-/media/Udgivelser/2016/NKR-l%C3%A6nderygsmerter/EN_260736-NKR---L%C3%A6ndesmerter-quickguide-english.ashx, accessed 2026-08-30.
- ASIPP — “Regenerative Medicine Guidelines,” https://asipp.org/regenerative-medicine-guidelines/, accessed 2026-08-30.